CAS: 6834-42-0; 2-(3-Methoxyphenyl)Acetyl Chloride

该化合物是有机化合物,其特点是其乙基氯功能组,附于一个甲基氧代苯环,该化合物一般是淡黄色液体无色的,以其反应作用而闻名,特别是阴化反应.乙基氯组的存在使它成为有机合成的一个有用中间体,允许将3-甲基苯乙基乙基混合物引入各种子体.重要的是要谨慎处理这一化合物,因为它可以是腐蚀性的,并且可能在水解过程中释放盐酸.此外,它对水体具有敏感性,这可能导致降解或意外的侧面反应.就溶性而言,3-甲基苯乙基氯在二氯乙烷和醚等有机溶剂中一般是溶解的,但在水中是溶解的.适当的安全防范措施,包括使用个人防护设备,对于与这一化合物合作时由于其潜在危害至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1798-09-0 3-甲氧基苯乙酸 | CAS号79-37-8 草酰氯 | CAS号121-71-1 3-羟基苯乙酮 | CAS号621-37-4 3-羟基苯乙酸 | CAS号35553-92-5 3-甲氧基苯基乙酸乙酯 | CAS号144828-84-2 N-甲氧基-2-(3-甲氧基苯... | CAS号20772-11-6 1-Bromo-3-(3-me... | CAS号18463-71-3 2-(3-甲氧基苯基)乙酰胺 | CAS号3027-13-2 3-甲氧基苯基丙酮 | CAS号76413-89-3 5-甲氧基-2-茚满酮 | CAS号33543-62-3 [2-(3-甲氧基苯基)乙基]甲胺 | CAS号324570-26-5 4-(3-甲氧基苯基)-3-氧代丁酸 | CAS号114547-01-2 1-diazonio-3-(3... | CAS号720690-73-3 GSK189254A

合成工艺路线路线简述

    3-羟基苯乙酸置于盐酸,Sodium Hydroxide,草酰氯体系中,用 苯 作为反应溶剂,化学反应 3.17H,反应生成 3-甲氧基苯基乙酰氯
    参考文献:合成育亨宾类生物碱和新型合成的(+/-)-17-甲氧基-六氢育亨宾
    标题:合成育亨宾类生物碱和新型合成的(+/-)-17-甲氧基-六氢育亨宾
    摘要:已经开发出一种新的合成(+/-)-17-甲氧基-六氢杂亚氨基b烷(11)的方法,该方法可以通过一系列反应转化为育亨宾类生物碱.所需合成的方法是基于选择6-甲氧基-3-异苯并二氢吡喃酮(9)作为构建非氮基部分的合适合成子.氮部分是由色胺产生的.9和色胺的适当缩合产生(+/-)-17-甲氧基-六氢育亨宾.通过baeyer-Villiger氧化由5-甲氧基-2-茚满酮(3)制备为δ-内酯的6-甲氧基-3-异苯并二氢吡喃酮(9).通过独特的酸催化的重氮酮环化,已经开发出一种简单的合成3的方法.在这方面值得一提的是,酸催化的环化反应容易用3-甲氧基-苄基重氮甲基酮(8)进行,而4-甲氧基苄基重氮甲基酮(2)则不愿意环化.在该方向上的所有尝试均导致形成羟基酮(4)作为主要产物.
    DOI:10.1016/s0040-4020(01)83466-9

    海关参考信息

    专利信息


    专利号:US-5623068-A
    优先权日:1994-03-07
    标 题:Synthesis of DNA using substituted phenylacetyl-protected nucleotides
    发明人:REDDY M PARAMESWARA; FAROOQUI FIRDOUS; HANNA NAEEM B
    权利人:BECKMAN INSTRUMENTS INC
    摘要:Deoxyribonucleotide and ribonucleotide derivatives of the general formula I I wherein R1 represents -CR'R''-Ar, in which Ar is substituted aryl (as hereinafter defined) and R' and R'' are independently selected from the group consisting of hydrogen and lower alkyl; one of -R2 and R3 is a hydroxyl-protecting group and the other is a group suitable for synthesis of polynucleotides or for attachment of the nucleotide to a solid support; R4 is selected from the group consisting of hydrogen, -OH and protected hydroxyl; and B represents a divalent radical corresponding to a purine or pyrimidine base. When synthesis is carried out using these derivatives, the deprotection procedure is reduced to an essentially instantaneous process. The derivatives have acceptable shelf life and are very stable to conventional DNA synthesis conditions. Particularly preferred are those compounds wherein Ar is mono- and dihalo-substituted phenyl.

    专利号:US-7098354-B2
    优先权日:2002-10-25
    标 题:Racemoselective synthesis of rac-diorganosilylbis(2-methylbenzo[e]indeyl)zirconium compounds
    发明人:DAMRAU HANS-ROBERT; MUELLER PATRIK; GARCIA VALERIE; SIDOT CHRISTIAN; TELLIER CHRISTIAN; LELONG JEAN-FRANCOIS
    权利人:BASELL POLYOLEFINE GMBH
    摘要:The present invention relates to a specific process for the diastereoselective synthesis of rac-diorganosilylbis(2-methylbenzo[e]indenyl)zirconium compounds of the formula I, n nby reacting the silyl-bridged bisindenyl ligand with a dihalozirconium bis(3,5-di-tert-butylphenoxide)-base adduct to form the diorganosilylbis(2-methylbenzo[e]indenyl)zirconium bis(3,5-di-tert-butylphenoxide) and subsequently replacing the phenoxide groups by X using suitable replacement reagents to give the compound of the formula I; where the substituents X can be identical or different and are each F, Cl, Br, I or linear, cyclic or branched C 1-10 -alkyl; and the substituents R can be identical or different and are each linear, cyclic or branched C 1-10 -alkyl or C 6-10 -aryl; and also to the use of these compounds as catalysts.

    专利号:US-6413957-B1
    优先权日:1998-04-21
    标题:Methods of inhibiting cell proliferation using indeno [1,2-c]pyrazol-4-ones
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
    权利人:BRISTOL MYERS SUIBB PHARMA COM
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-8481501-B2
    优先权日:2004-05-28
    标 题 :Synthesis of metabolically stable analgesics, pain medications and other agents
    发明人:CASHMAN JOHN R; MACDOUGALL JAMES M
    权利人:CASHMAN JOHN R; MACDOUGALL JAMES M; HUMAN BIOMOLECULAR RES INST
    摘要:Disclosed are analgesic-related compositions and methods of using the compositions for modulation of analgesic receptor activity. The compositions and methods are useful for reducing pain, as well as for therapeutic intervention of addictions or other diseases or disorders amenable to treatment or prophylaxis by modulation of analgesic receptor signaling.

    专利号:US-7250435-B2
    优先权日:1999-10-20
    标 题:Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; VIDWANS ANUP P; YUE EDDY
    权利人:BRISTOL MYERS SQUIBB PHARMA CO
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): n nthat are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and their regulatory subunits know as cyclins A-G.n n This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-7193099-B2
    优先权日:2002-10-25
    标 题:Racemoselective preparation of isolable ansa-metallocene biphenoxide complexes
    发明人:DAMRAU HANS-ROBERT-HELLMUTH; MUELLER PATRIK; GARCIA VALERIE; SIDOT CHRISTIAN; TELLIER CHRISTIAN; LELONG JEAN-FRANCOIS
    权利人:BASELL POLYOLEFINE GMBH
    摘要:The invention relates to a process for preparing racemic metallocene biphenoxide complexes by reacting bridged transition metal complexes with cyclopentadienyl derivatives of alkali metals or alkaline earth metals and heating the reaction mixture obtained in this way to a temperature in the range from −78 to 250° C., to the corresponding metallocene biphenoxide complexes and to their use as catalysts or as constituents of catalysts for the polymerization of olefinically unsaturated compounds or as reagents or catalysts in stereoselective synthesis.
    济南大宇化工有限公司控股公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司控股公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com
    通信地址: 济南市济阳区济北生命科技园
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市济阳区济北生命科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京偶合科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ouhechem.com
    企业联系电话:010-51280831(不占线);010-82967028👤
    📞北京偶合科技有限公司 ⚠️参考联系方式
    联系人:刘先生
    电话:010-51280831(不占线);010-82967028
    手机:13911808554
    传真:010-82967029
    邮箱:sales@ouhechem.com
    通信地址: 北京市海淀区西三旗桥东上奥世纪2b-1328室
    邮编: 100096
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三旗桥东上奥世纪2b-1328室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf00406242
    摘要:Schneider MR, Schönenberger H, Michel RT, Fortmeyer HP. Synthesis and evaluation of catechol analogs of diethylstilbestrol on a hormone-dependent human mammary carcinoma implanted in nude mice. Journal of Cancer Research and Clinical Oncology. 1982 Oct;104(3):219–27. doi: 10.1007/bf00406242.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知